Molecular interactions between piperine and peroxisome proliferator-activated receptor gamma ligand-binding domain revealed using co-crystallization studies. [PDF]
Egawa D, Ishida H, Katakawa K.
europepmc +1 more source
Understanding beliefs about elexacaftor-tezacaftor-ivacaftor therapy in adults living with cystic fibrosis. [PDF]
O'Leary C +5 more
europepmc +1 more source
Aldehyde Dehydrogenase-2 Alleviates Septic Myocardial Injury by Inhibiting Caspase-11-Mediated Noncanonical Pyroptosis. [PDF]
Liang H +7 more
europepmc +1 more source
The Activation of Aldehyde Dehydrogenase 2 (ALDH2) by Alda-1 and Flurbiprofen as a Common Mechanism to Reduce Alcohol Intake in Rats. [PDF]
Torres JM +6 more
europepmc +1 more source
Impact of COVID-19 and CFTR Modulators on Cystic Fibrosis: A Real-World Analysis of Care Patterns. [PDF]
Hinton AC +3 more
europepmc +1 more source
Cepharanthine inhibits the proliferation and epithelial-mesenchymal transition of oral squamous cell carcinoma via HMGA2/FOXL2 axis. [PDF]
Huang Y, Huang J, Zhang X.
europepmc +1 more source
Physiologically Based Pharmacokinetic Modeling of Elexacaftor/Tezacaftor/Ivacaftor in Infants With Cystic Fibrosis. [PDF]
Truong NH +16 more
europepmc +1 more source
Piperine and Tabersonine, but Not Lupinine, Inhibit <i>S. proteamaculans</i> Invasion of M-HeLa Cells. [PDF]
Bozhokina E, Berson Y, Tsaplina O.
europepmc +1 more source
Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial. [PDF]
Durham L +5 more
europepmc +1 more source
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis. [PDF]
Gramegna A +7 more
europepmc +1 more source

